Abstract
Purpose
This study compared the subjective quality of life (SQOL) in schizophrenia patients living with their families in Hong Kong (HK) and Beijing (BJ) and explored the relationship between SQOL and basic socio-demographic and clinical factors.
Materials and methods
Two hundred and sixty-four clinically stable outpatients with schizophrenia were randomly selected in HK and 258 counterparts matched according to age, sex, age at onset, and length of illness in BJ. SQOL and psychiatric status were assessed with standard rating instruments.
Results
There was no significant difference in any of SQOL domains between the two cohorts after controlling for potentially confounding variables. Positive, depressive and anxiety symptoms and drug-induced extrapyramidal side effects (EPS) were all significantly correlated with SQOL. Multiple regression analysis revealed that only depressive symptoms predicted all SQOL domains in both groups. Having removed depressive symptoms from the model, positive symptoms predicted all domains, anxiety predicted all but social domains, use of benzodiazepines (BZD) predicted all but physical domains, EPS predicted physical domain, and history of suicide predicted social domain in HK; anxiety predicted all domains, positive symptoms predicted all but physical domains, EPS, use of BZD and history of suicide all predicted physical domains, and length of illness predicted environmental domain in BJ.
Conclusion
Despite considerable differences between the two sites in terms of health care delivery and the economic conditions of the subjects, SQOL did not differ between HK and BJ. The conclusion is in line with previous studies that suggested that patients’ SQOL was independent of their living standard as long as it reached a certain minimum level. SQOL was more strongly related to the severity of depressive symptoms and had weak association with socio-demographic factors.
Similar content being viewed by others
References
Xiang, Y., Weng, Y., Li, W., Gao, L., Chen, G., Xie, L., Chang, Y., Tang, W. K., & Ungvari, G. S. (2006). Training patients with schizophrenia with the community re-entry module: A controlled study. Social Psychiatry and Psychiatric Epidemiology, 41, 464–469.
Chen, C. H., Shen, Y. C., Zhang, W. X., Li, S. R., Huang, Y. Q., Wang, J. R., & Wang, D. P. (1998). Epidemiological survey on schizophrenia in seven areas of China (in Chinese). The Chinese Journal of Psychiatry, 31, 72–74.
Weng, Y. Z., Xu, M. J., Li, D. L, Guo, F. Y., Huang, Q., & Fu, T. (2001). Assessment of expressed emotion in family members of schizophrenic patients in Beijing. Modern Rehabilitation, 5, 39–42.
Phillips, M. R., & Pearson, V. (1994). Future opportunities and challenges for the development of psychiatric rehabilitation in China. The British Journal of Psychiatry, 165(Suppl), 128–142.
Sartorius, N. (1997). Quality of life and mental disorders: A global perspective. Chichester: John Wiley.
Browne, S., Roe, M., Lane, A., Gervin, M., Morris, M., Kinsella, A., Larkin, C., & Callaghan, E. O. (1996). Quality of life in schizophrenia: Relationship to sociodemographic factors, symptomatology and tardive dyskinesia. Acta Psychiatrica Scandinavica, 94, 118–124.
Law, C. W., Chen, E. Y., Cheung, E. F., Chan, R. C., Wong, J. G., Lam, C. L., Leung, K. F., & Lo, M. S. (2005). Impact of untreated psychosis on quality of life in patients with first-episode schizophrenia. Quality of Life Research, 14, 1803–1811.
Bechdolf, A., Klosterkotter, J., Hambrecht, M., Knost, B., Kuntermann, C., Schiller, S., & Pukrop, R. (2003). Determinants of subjective quality of life in post acute patients with schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 253, 228–235.
Ponizovsky, A. M., Grinshpoon, A., Levav, I., & Ritsner, M. S. (2003). Life satisfaction and suicidal attempts among persons with schizophrenia. Comprehensive Psychiatry, 44, 442–447.
Warner, R., de Girolamo, G., Belelli, G., Bologna, C., Fioritti, A., & Rosini, G. (1998). The quality of life of people with schizophrenia in Boulder, Colorado, and Bologna, Italy. Schizophrenia Bulletin, 24, 559–568.
Heinze, M., Taylor, R. E., Priebe, S., & Thornicroft, G. (1997). The quality of life of patients with paranoid schizophrenia in London and Berlin. Social Psychiatry and Psychiatric Epidemiology, 32, 292–297.
Chan, G. W., Ungvari, G. S., Shek, D. T., & Leung Dagger, J. J. (2003). Hospital and community-based care for patients with chronic schizophrenia in Hong Kong—quality of life and its correlates. Social Psychiatry and Psychiatric Epidemiology, 38, 196–203.
Tan, H. Y., Choo, W. C., Doshi, S., Lim, L. E., & Kua, E. H. (2004). A community study of the health-related quality of life of schizophrenia and general practice outpatients in Singapore. Social Psychiatry and Psychiatric Epidemiology, 39, 106–112.
Lobana, A., Mattoo, S. K., Basu, D., & Gupta, N. (2001). Quality of life in schizophrenia in India: Comparison of three approaches. Acta Psychiatrica Scandinavica, 104, 51–55.
Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). New York: Erlbaum Hillsdale.
Fang, J. Q., Hao, Y. T., & Li, C. X. (1999). Reliability and validity for Chinese version of WHO quality of life scale (in Chinese). Chinese Mental Health Journal, 13, 203–205.
WHO (1995). The World Health Organization Quality of Life assessment (WHOQOL): Position paper from the World Health Organization. Social Science & Medicine, 41, 1403–1409.
Overall, J. E., & Beller, S. A. (1984). The Brief Psychiatric Rating Scale (BPRS) in geropsychiatric research: I. Factor structure on an inpatient unit. Journal of Gerontology, 39, 187–193.
Simpson, G. M., & Angus, J. W. (1970). A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica Supplementum, 212, 11–19.
Barnes, T. R. (1989). A rating scale for drug-induced akathisia. The British Journal of Psychiatry, 154, 672–676.
Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry, 23, 56–62.
Wegener, S., Redoblado-Hodge, M. A., Lucas, S., Fitzgerald, D., Harris, A., & Brennan, J. (2005). Relative contributions of psychiatric symptoms and neuropsychological functioning to quality of life in first-episode psychosis. The Australian and New Zealand Journal of Psychiatry, 39, 487–492.
Corrigan, P. W., & Buican, B. (1995). The construct validity of subjective quality of life for the severely mentally ill. The Journal of Nervous and Mental Disease, 183, 281–285.
Hofer, A., Kemmler, G., Eder, U., Edlinger, M., Hummer, M., & Fleischhacker, W. W. (2004). Quality of life in schizophrenia: The impact of psychopathology, attitude toward medication, and side effects. The Journal of Clinical Psychiatry, 65, 932–939.
Hansson, L., Middelboe, T., Sorgaard, K. W., Bengtsson-Tops, A., Bjarnason, O., Merinderv, L., Nilsson, L., Sandlund, M., Korkeila, J., & Vinding, H. R. (2002). Living situation, subjective quality of life and social network among individuals with schizophrenia living in community settings. Acta Psychiatrica Scandinavica, 106, 343–350.
Patterson, T. L., Shaw, W., Semple, S. J., Moscona, S., Harris, M. J., Kaplan, R. M., Grant, I., & Jeste, D. V. (1997). Health-related quality of life in older patients with schizophrenia and other psychoses: Relationships among psychosocial and psychiatric factors. International Journal of Geriatric Psychiatry, 12, 452–461.
Eronen, M. (1995). Mental disorders and homicidal behavior in female subjects. The American Journal of Psychiatry, 152, 1216–1218.
Yuen, C. H. (2004). Guideline on PFU system. In Doctors’ handbook. Hong Kong: Castle Peak Hospital.
Luo, K., & Yu, D. (1994). Enterprise-based sheltered workshops in Nanjing. A new model for the community rehabilitation of mentally ill workers. The British Journal of Psychiatry Supplement, 165, 89–95.
Phillips, M. R., Lu, S. H., & Wang, R. W. (1997). Economic reforms and the acute inpatient care of patients with schizophrenia: The Chinese experience. The American Journal of Psychiatry, 154, 1228–1234.
Ng, C. (2007). Role of international collaboration in facilitating mental halth system change. In WPA Regional Conference/CSP Annual Congress. Shanghai, China, September 20–23, pp. 162–163.
Sim, K., Su, A., Fujii, S., Yang, S. Y., Chong, M. Y., Ungvari, G. S., Si, T., Chung, E. K., Tsang, H. Y., Chan, Y. H., Heckers, S., Shinfuku, N., & Tan, C. H. (2004). Antipsychotic polypharmacy in patients with schizophrenia: A multicentre comparative study in East Asia. British Journal of Clinical Pharmacology, 58, 178–183.
Skantze, K., Malm, U., Dencker, S. J., May, P. R., & Corriganv, P. (1992). Comparison of quality of life with standard of living in schizophrenic out-patients. The British Journal of Psychiatry, 161, 797–801.
Fitzgerald, P. B., Williams, C. L., Corteling, N., Filia, S. L., Brewer, K., Adams, A., de Castella, A. R., Rolfe, T., Davey, P., & Kulkarni, J. (2001). Subject and observer-rated quality of life in schizophrenia. Acta Psychiatrica Scandinavica, 103, 387–392.
Larsen, E. B., & Gerlach, J. (1996). Subjective experience of treatment, side-effects, mental state and quality of life in chronic schizophrenic out-patients treated with depot neuroleptics. Acta Psychiatrica Scandinavica, 93, 381–388.
Lehman, A. F. (1988). A quality of life interview for the chronically mentally ill. Evaluation and Program Planning, 11, 51–62.
Huppert, J. D., & Smith, T. E. (2001). Longitudinal analysis of subjective quality of life in schizophrenia: Anxiety as the best symptom predictor. The Journal of Nervous and Mental Disease, 189, 669–675.
Awad, A. G. (1992). Quality of life of schizophrenic patients on medications and implications for new drug trials. Hospital & Community Psychiatry, 43, 262–265.
Micallef, J., Fakra, E., & Blin, O. (2006). Use of antidepressant drugs in schizophrenic patients with depression. Encephale, 32, 263–269.
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S., Davis, S. M., Davis, C. E., Lebowitz, B. D., Severe, J., & Hsiao, J. K. (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. The New England Journal of Medicine, 353, 1209–1223.
Jones, P. B., Barnes, T. R., Davies, L., Dunn, G., Lloyd, H., Hayhurst, K. P., Murray, R. M., Markwick, A., & Lewis, S. W. (2006). Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Archives of General Psychiatry, 63, 1079–1087.
Acknowledgements
The authors would like to thank the staff of the Day Hospital at Shatin Hospital, the Li Ka Shing Psychiatric Outpatient Clinic at Prince of Wales Hospital and the General Outpatient Department at Beijing Anding Hospital for their assistance in the project.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Xiang, YT., Weng, YZ., Leung, CM. et al. Subjective quality of life in outpatients with schizophrenia in Hong Kong and Beijing: relationship to socio-demographic and clinical factors. Qual Life Res 17, 27–36 (2008). https://doi.org/10.1007/s11136-007-9285-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-007-9285-2